Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Delayed puberty linked to reduced risk of systemic sclerosis

29 Nov 2019

Women with late age at menarche are at much lower risk of developing systemic sclerosis (SSc), a study suggests. Furthermore, abortion does not contribute to a risk increase.

The study included 116 SSc patients (mean age, 46.74 years) and 392 female controls (mean age, 48.13 years) of Chinese Han ethnicity. All the women completed structured questionnaires to assess reproductive and menstrual factors, including number of births, abortions and age at menarche.

Compared with controls, SSc patients had a comparable level of education, with illiteracy predominating in both groups. Additionally, more SSc patients vs controls had body mass index (BMI) <18.5 kg/m2, had poor sleep quality and were exposed to passive smoking.

Unconditional logistics regression showed that the risk of developing SSc was lower in women with late (≥17 years) vs early menarche age (odds ratio [OR] 0.347, 95 percent confidence interval [CI], 0.174–0.693) and in those with abortion (one time) vs without abortion (OR, 0.601, 95 percent CI, 0.408–0.887).

On further analysis that controlled for potential confounders such as occupation and BMI, the protective association observed for late age at menarche persisted (OR, 0.187, 95 percent CI, 0.068–0.513) but not that for abortions. A meta-analysis confirmed that there was no association between SSc and abortions or number of pregnancies. No significant publication bias was observed (p>0.05).

Additional investigation is required to establish the role of menstruation timing in the aetiology of SSc, the researchers noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.